A recent publication from the Kimberly Lab in Nature Communications has shown that portable MRI and machine learning can detect structural changes in the brains of patients with Alzheimer’s disease (https://doi.org/10.1038/s41467-024-54972-x).
This Thanksgiving, the Kimberly Lab took time to reflect and express gratitude for the aspects of their research lives they value, with the help of the MGB Media Team.
The Kimberly Lab has fully engaged in National Postdoc Appreciation Week!
The Kimberly Lab recently published an article in Neurology that found an association between ultra-processed food consumptions and adverse brain health outcomes, including cognitive impairment and stroke.
Dr Kimberly recently presented the findings of the world-first phase III trial of glibenclamide for large hemispheric ischaemic stroke at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.
Dr Sorby-Adams presented cutting-edge portable MRI at the 2024 International Stroke Conference (ISC) regarding data showing that portable MRI can identify hyperacute ischaemic stroke.
Working with collaborators at Martinos, Yale and Hyperfine Research, we’re developing a low-cost, low-field, portable MRI scanner for clinical use.
The Harvard Catalyst ThinkResearch team invited Taylor Kimberly back to talk about recent advances in clinical trials in stroke.
Dr. Kimberly was interviewed by Neurovascular Exchange to provide expert comment on a recent study.
Lab members gave 5 oral and poster presentations. Aloha from Honolulu!
